Daan van Doorn (D.P.C.)
Research profile
Thrombotic microangiopathy
ANCA-associated vasculitis
Complement system
Coagulation
Research projects
Complement Prospective Evaluation of Thrombotic Microangiopathy on Endothelium (COMPETE)
ClinicalTrials.gov ID: NCT04745195
Junior Talent Kolff+ grant of dr. Sjoerd A.M.E.G. Timmermans
Key publications
-
van Doorn, D. P. C., Tobal, R., Abdul-Hamid, M. A., van Paassen, P., Timmermans, S. A. M. E. G., & Limburg Renal Registry (2025). Etiology and outcomes of kidney-limited and systemic thrombotic microangiopathy. Modern Pathology, 38(4), Article 100690. https://doi.org/10.1016/j.modpat.2024.100690More information about this publication
-
van Doorn, D. P. C., van Paassen, P., & Timmermans, S. A. M. E. G. (2024). Kidney-limited TMA is common in patients with complement dysregulation. Kidney International, 106(3), 536-537. https://doi.org/10.1016/j.kint.2024.06.009More information about this publication
-
van Doorn, D. P. C., Abdul-Hamid, M. A., Frenken, L. A. M., van Paassen, P., & Timmermans, S. A. M. E. G. (2024). The spectrum of thrombotic microangiopathy related to monoclonal gammopathy. Clinical Kidney Journal, 17(1), Article sfad306. https://doi.org/10.1093/ckj/sfad306More information about this publication
-
Timmermans, S. A. M. E. G., van Doorn, D. P. C., & van Paassen, P. (2025). Toward a Revised Definition of Thrombotic Microangiopathy. Kidney International Reports, 10(6), 1625-1627. https://doi.org/10.1016/j.ekir.2025.04.051More information about this publication